EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Yu-Ying Xu, Wen-Tan Xu, Wei-Ping Pan, Xie-Li Guo, Xiao-Min Li, Su-Mei Xu, Shao-Wei Yan, Wen-Ke Cai, Xin-Bin Yan, Wen-Jing Zhong, Shi-Lin Chen, Ping-Sheng Xu

Clinical Pharmacology in Drug Development · 2025

DOI: 10.1002/cpdd.1597 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, 2025. Verfasst von Yu-Ying Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian), Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Amlodipine, Antihypertensive Agents, Fasting, Valsartan. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assessed the pharmacokinetics (PK) and bioequivalence (BE) of valsartan and amlodipine (80/5 mg) tablets in healthy Chinese subjects under fasting and fed conditions. A randomized, open‐label, four‐period crossover trial was conducted, with participants receiving test (T) or reference (R) formulations in cycles separated by a 14‐day washout. Plasma concentrations of valsartan and amlodipine were measured using high‐performance liquid chromatography‐tandem mass spectrometry. PK parameters were analyzed noncompartmentally, and BE was evaluated using reference‐scaled average bioequivalence (RSABE) for high‐variability parameters (CV W ≥ 30%) and average bioequivalence (ABE) for low‐variability parameters (CV W < 30%). Under fasting conditions, the maximum concentration of drug in blood plasma (C max ) of valsartan was assessed using RSABE methodology and demonstrated bioequivalence. For amlodipine, bioequivalence was established through conventional ABE analysis, with the 90% confidence intervals (CIs) for the geometric mean ratios (GMRs) of C max , AUC 0‐t , and AUC 0‐∞ all residing within the predefined equivalence boundaries. Under postprandial conditions, both drugs met BE criteria using ABE, with 90% CIs of GMRs within the acceptable range. Importantly, postprandial administration resulted in a significant reduction of approximately 30% in systemic exposure of valsartan for both test and reference formulations. All adverse events were mild and transient. The T and R formulations demonstrated bioequivalence and were well tolerated, supporting their interchangeability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmlodipineAntihypertensive AgentsFastingValsartanAdultFemaleHumansMaleYoung AdultAdministration, OralArea Under CurveChinaChromatography, High Pressure LiquidCross-Over StudiesFood-Drug InteractionsHealthy VolunteersTabletsTandem Mass SpectrometryTherapeutic EquivalencyEast Asian People

Stichwörter der Autor:innen

amlodipinebioequivalencepharmacokineticssafetyvalsartan

Substanzen

AmlodipineAntihypertensive AgentsTabletsValsartan

Autor:innen und Institutionen

  • Department of Pharmacy, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian), Quanzhou, Fujian, China.
  • Drug Clinical Trial Institution, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian Campus), Quanzhou, Fujian, China.
  • Phase I Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Research and Development Department, Chengdu Brilliant Pharmaceutical Co., Ltd., Chengdu, Sichuan, China.
  • Analysis and Testing Department, Chengdu Finelyse Pharmaceutical Technology Co., Ltd., Chengdu, Sichuan, China.

Zitieren

APA

Xu, Y. Y., Xu, W. T., Pan, W. P., Guo, X. L., Li, X. M., Xu, S. M., Yan, S. W., Cai, W. K., Yan, X. B., Zhong, W. J., Chen, S. L., & Xu, P. S. (2025). Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1597

Vancouver

Xu YY, Xu WT, Pan WP, Guo XL, Li XM, Xu SM, et al. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Clinical Pharmacology in Drug Development. 2025. doi:10.1002/cpdd.1597

BibTeX
@article{Xu2025,
  author = {Xu, Yu-Ying and Xu, Wen-Tan and Pan, Wei-Ping and Guo, Xie-Li and Li, Xiao-Min and Xu, Su-Mei and Yan, Shao-Wei and Cai, Wen-Ke and Yan, Xin-Bin and Zhong, Wen-Jing and Chen, Shi-Lin and Xu, Ping-Sheng},
  title = {Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2025},
  doi = {10.1002/cpdd.1597}
}
Kostenlos starten →